67 related articles for article (PubMed ID: 16000067)
1. Efficient inhibition of human telomerase reverse transcriptase expression by RNA interference sensitizes cancer cells to ionizing radiation and chemotherapy.
Nakamura M; Masutomi K; Kyo S; Hashimoto M; Maida Y; Kanaya T; Tanaka M; Hahn WC; Inoue M
Hum Gene Ther; 2005 Jul; 16(7):859-68. PubMed ID: 16000067
[TBL] [Abstract][Full Text] [Related]
2. Targeting telomerase reverse transcriptase with the covalent inhibitor NU-1 confers immunogenic radiation sensitization.
Liu Y; Betori RC; Pagacz J; Frost GB; Efimova EV; Wu D; Wolfgeher DJ; Bryan TM; Cohen SB; Scheidt KA; Kron SJ
Cell Chem Biol; 2022 Oct; 29(10):1517-1531.e7. PubMed ID: 36206753
[TBL] [Abstract][Full Text] [Related]
3. Telomerase-Mediated Self-Assembly of DNA Network in Cancer Cells Enabling Mitochondrial Interference.
Guo Y; Li S; Tong Z; Tang J; Zhang R; Lv Z; Song N; Yang D; Yao C
J Am Chem Soc; 2023 Nov; 145(43):23859-23873. PubMed ID: 37857277
[TBL] [Abstract][Full Text] [Related]
4. New therapeutic strategies based on interference with telomeric DNA synthesis of tumor cells to suppress the growth of tumors.
Wang Z; Zhao X; Liu Y; Wang T; Li K
RSC Adv; 2018 Jul; 8(44):25001-25007. PubMed ID: 35542162
[TBL] [Abstract][Full Text] [Related]
5. Editor's Note: Delivery of Telomerase Reverse Transcriptase Small Interfering RNA in Complex with Positively Charged Single-Walled Carbon Nanotubes Suppresses Tumor Growth.
Zhang Z; Yang X; Zhang Y; Zeng B; Wang S; Zhu T; Roden RBS; Chen Y; Yang R
Clin Cancer Res; 2024 Feb; 30(4):923. PubMed ID: 38362724
[No Abstract] [Full Text] [Related]
6. MRI radiomics model for predicting TERT promoter mutation status in glioblastoma.
Chen L; Chen R; Li T; Huang L; Tang C; Li Y; Zeng Z
Brain Behav; 2023 Dec; 13(12):e3324. PubMed ID: 38054695
[TBL] [Abstract][Full Text] [Related]
7. ZEB1 promotes DNA homologous recombination repair and contributes to the 5-Fluorouracil resistance in colorectal cancer.
Wu C; Shi W; Zhang S
Am J Cancer Res; 2023; 13(9):4101-4114. PubMed ID: 37818077
[TBL] [Abstract][Full Text] [Related]
8. Knockdown of the stem cell marker Musashi-1 inhibits endometrial cancer growth and sensitizes cells to radiation.
Falke I; Troschel FM; Palenta H; Löblein MT; Brüggemann K; Borrmann K; Eich HT; Götte M; Greve B
Stem Cell Res Ther; 2022 May; 13(1):212. PubMed ID: 35619161
[TBL] [Abstract][Full Text] [Related]
9. Radiotherapy in Medulloblastoma-Evolution of Treatment, Current Concepts and Future Perspectives.
Seidel C; Heider S; Hau P; Glasow A; Dietzsch S; Kortmann RD
Cancers (Basel); 2021 Nov; 13(23):. PubMed ID: 34885055
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of Human Telomerase Reverse Transcriptase (
Yik MY; Azlan A; Rajasegaran Y; Rosli A; Yusoff NM; Moses EJ
Genes (Basel); 2021 Jul; 12(8):. PubMed ID: 34440361
[TBL] [Abstract][Full Text] [Related]
11. hTERT Downregulation Attenuates Resistance to DOX, Impairs FAK-Mediated Adhesion, and Leads to Autophagy Induction in Breast Cancer Cells.
Romaniuk-Drapała A; Totoń E; Konieczna N; Machnik M; Barczak W; Kowal D; Kopczyński P; Kaczmarek M; Rubiś B
Cells; 2021 Apr; 10(4):. PubMed ID: 33920284
[TBL] [Abstract][Full Text] [Related]
12. Cancer-specific loss of
Amen AM; Fellmann C; Soczek KM; Ren SM; Lew RJ; Knott GJ; Park JE; McKinney AM; Mancini A; Doudna JA; Costello JF
Proc Natl Acad Sci U S A; 2021 Mar; 118(13):. PubMed ID: 33758097
[TBL] [Abstract][Full Text] [Related]
13. Effect of therapies-mediated modulation of telomere and/or telomerase on cancer cells radiosensitivity.
Assani G; Xiong Y; Zhou F; Zhou Y
Oncotarget; 2018 Oct; 9(79):35008-35025. PubMed ID: 30405890
[TBL] [Abstract][Full Text] [Related]
14. Concomitant underexpression of TGFBR2 and overexpression of hTERT are associated with poor prognosis in cervical cancer.
Yang H; Zhang H; Zhong Y; Wang Q; Yang L; Kang H; Gao X; Yu H; Xie C; Zhou F; Zhou Y
Sci Rep; 2017 Feb; 7():41670. PubMed ID: 28195144
[TBL] [Abstract][Full Text] [Related]
15. Short-term inhibition of TERT induces telomere length-independent cell cycle arrest and apoptotic response in EBV-immortalized and transformed B cells.
Celeghin A; Giunco S; Freguja R; Zangrossi M; Nalio S; Dolcetti R; De Rossi A
Cell Death Dis; 2016 Dec; 7(12):e2562. PubMed ID: 28032863
[TBL] [Abstract][Full Text] [Related]
16. Targeting telomerase with radiolabeled inhibitors.
Waghorn PA; Jackson MR; Gouverneur V; Vallis KA
Eur J Med Chem; 2017 Jan; 125():117-129. PubMed ID: 27657809
[TBL] [Abstract][Full Text] [Related]
17. Telomerase Activation in Hematological Malignancies.
Ropio J; Merlio JP; Soares P; Chevret E
Genes (Basel); 2016 Sep; 7(9):. PubMed ID: 27618103
[TBL] [Abstract][Full Text] [Related]
18. Enhanced inhibition of clonogenic survival of human medulloblastoma cells by multimodal treatment with ionizing irradiation, epigenetic modifiers, and differentiation-inducing drugs.
Patties I; Kortmann RD; Menzel F; Glasow A
J Exp Clin Cancer Res; 2016 Jun; 35(1):94. PubMed ID: 27317342
[TBL] [Abstract][Full Text] [Related]
19. The DNA methylation inhibitor induces telomere dysfunction and apoptosis of leukemia cells that is attenuated by telomerase over-expression.
Zhang X; Li B; de Jonge N; Björkholm M; Xu D
Oncotarget; 2015 Mar; 6(7):4888-900. PubMed ID: 25682873
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of telomeric repeat binding factor 2 enhances tumor radiosensitivity regardless of telomerase status.
Yang X; Li Z; Yang L; Lei H; Yu H; Liao Z; Zhou F; Xie C; Zhou Y
J Cancer Res Clin Oncol; 2015 Sep; 141(9):1545-52. PubMed ID: 25609072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
